TNFRSF10A and lymphoma: Human agonistic mAbs HGS-ETR1 (anti-DR4) and HGS-ETR2 (anti-DR5) killed myeloma and lymphoma cells through caspase activation and cleavage of myeloid cell leukemia-1L [29].